Zydus Cadila has approached India’s top drug regulator for restricted emergency approval of ZyCov-D, its three-dose Covid-19 vaccine. If granted, this would be the first DNA vaccine available in the world.
The company, which has also been evaluating the possibility of using a two-dose regimen of ZyCov-D, said that the immunogenicity results “had been found to be equivalent to the current three-dose regimen” — two doses of the vaccine were able to prompt an immune response that was just as good as the response in a three-dose regimen
Dysautonomia: The Silent Illness Impacting Millions of People Worldwide Dysautonomia is an umbrella term used…
https://youtu.be/mdl3AFFFcuk?si=i2cYzTX7WJ-z6wRp Does Chyawanprash Help in Cough & Cold? Exploring Its Benefits and Efficacy Chyawanprash, a…
Walk In Winter: In winter, the time from 7:00 AM to 9:00 AM is considered…
Does Maida Stick To Your Gut Lining: In this article, we debunk the common myth…
https://youtu.be/4NTKSfNf1TM?si=Y4xkEOKDUvqpIEZt The Disadvantages of Heating Packaged Milk Milk is a staple in many households and…
A recent study has revealed a growing mental health crisis among teenagers globally, with nearly…